← Leaderboards
Alexander J Gill
University Of Pennsylvania
$106,069
Attributed
$106,069
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.1K · FY2014–16$50K$37.5K$25K$12.5K$0
'14
'15
'16
Funding mix
By agency
NIH$106,069 · 1
By mechanism
F30$106,069 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kelly L Jordan-Sciutto$26,892,677
- Dennis Larry Kolson$16,900,832
- Judith B Grinspan$7,508,303
- Ronald G Collman$30,299,814
- Narayan G Avadhani$16,577,650
Others in their field
Top investigators on “Anti-Inflammatory Agents”
- John C S Breitner · Johns Hopkins University$45,650,942
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- Ulrike Peters · Fred Hutchinson Cancer Research Center$32,742,974
- Mohammad Athar · Columbia University Health Sciences$23,570,567
- Joren C Madsen · Massachusetts General Hospital$23,154,977
- Vladimir R Muzykantov · University Of Pennsylvania$18,661,413
Research focus
Anti-Inflammatory AgentsAntioxidantsAntiretroviral TherapyBehavioralBlood - Brain Barrier AnatomyBrainBrain RegionBrain TissueCd4 Positive T LymphocytesCerebral AtrophyChronic Kidney FailureClinical ResearchCognitiveCytokineDegradation PathwayDisease MarkerDisease ProgressionEnzymesEstersExcitatory NeurotoxinsFumaratesFumaric AcidGlutamatesAnti-Inflammatory
Grant awards (3)
Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegeneration$30,222
F30 · FY2016 · MH · contact PI
Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegeneration$29,766
F30 · FY2015 · MH · contact PI
Heme Oxygenase-1 as a novel therapeutic target in HIV-mediated neurodegeneration$46,081
F30 · FY2014 · MH · contact PI